Save Spravato as a Last-Line Option for Resistant Depression

May 2019

You'll hear buzz about new Rx Spravato (sprah-VAH-toh, esketamine) nasal spray for treating adults with resistant depression.

Some experts already use low-dose IV ketamine infusions in these patients...since growing data suggest this may "jump-start" improvement.

Spravato is the active isomer of ketamine. Both block N-methyl-D-aspartate (NMDA) receptors.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Aspirin Be Ready With Answers About Aspirin for CV Disease Prevention
Depression Save Spravato as a Last-Line Option for Resistant Depression
Antithrombotics Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib
Dermatology Prepare Patients for Actinic Keratosis Treatment
Parkinson's Disease Save Inbrija for "Off" Episodes of Parkinson's Despite Optimized Meds
Beta-Blockers Don't Shy Away From Selective Beta-Blockers in Most COPD or Asthma Patients
Ophthalmology Lean Away From Cequa for Dry Eyes
Establish Boundaries for Prescribing Meds for Yourself or Family
Infectious Diseases Be Prepared to Manage Osteomyelitis Patients on Oral Antibiotics
ADHD Put Psychosis Risk for ADHD Stimulants in Perspective
Women's Health Expect Limited Use of IV Brexanolone (Zulresso) for Postpartum Depression